ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982